BioSignal Group
Private Company
Funding information not available
Overview
BioSignal Group, founded in 2010 and based in Boston, MA, is a private digital health company commercializing the microEEG platform—a portable, easy-to-use electroencephalogram (EEG) system. The technology addresses critical gaps in access to rapid brain function assessment by enabling setup by non-specialists in five minutes and providing remote interpretation by board-certified neurologists within an hour. Its primary markets are hospital emergency/acute care and sports concussion management, where timely diagnosis is crucial for patient outcomes.
Technology Platform
microEEG® platform: an FDA-cleared, miniature, wireless EEG recorder paired with disposable headpieces and a telemedicine platform for rapid remote interpretation by neurologists.
Opportunities
Risk Factors
Competitive Landscape
Competes against traditional, bulky EEG systems from companies like Natus Medical and Nihon Kohden. Faces emerging competition from other portable/wireless EEG startups (e.g., Ceribell) and a growing array of consumer neurowearables that may seek clinical validation. Its integrated hardware/telemedicine service is a key differentiator.